Related Experiment Video
Updated: Dec 22, 2025
04:55
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
1.2K
Cardiomyopathy in the pediatric patients
1Department of Cardiothoracic Surgery, The First Hospital of Putian, Teaching Hospital, Fujian Medical University, Putian, Fujian Province, People's Republic of China.
Pediatrics and Neonatology
|February 19, 2018
Summary
Pediatric cardiomyopathies, a growing concern in children, are myocardial diseases leading to heart failure. Early diagnosis via imaging and biopsy, alongside tailored treatments, is crucial for improving survival rates.
Area of Science:
- Pediatric Cardiology
- Myocardial Diseases
- Genetics
Background:
- Pediatric cardiomyopathies are myocardial diseases affecting children of all ages.
- These conditions are a leading cause of heart failure and heart transplantation in pediatric populations.
- The incidence of pediatric cardiomyopathy is rising, often presenting with comorbidities like arrhythmia and sudden death.
Purpose of the Study:
- To provide a comprehensive overview of pediatric cardiomyopathies.
- To highlight diagnostic modalities and therapeutic strategies.
- To emphasize the importance of individualized treatment for improved outcomes.
Main Methods:
- Review of medical imaging technologies (echocardiography, cardiac MRI, nuclear cardiology).
- Emphasis on endomyocardial biopsy as the definitive diagnostic tool.
- Discussion of surgical interventions and pharmaceutical therapies.
Main Results:
- Medical imaging aids in diagnosis, but endomyocardial biopsy remains the gold standard.
- Surgical options are considered when medical therapies fail.
- Individualized treatment regimens are key to enhancing patient survival.
Conclusions:
- Pediatric cardiomyopathies require complex diagnostic approaches.
- Effective management involves a combination of advanced imaging, biopsy, and tailored medical or surgical interventions.
- Personalized therapeutic strategies considering pediatric-specific factors are essential for better patient prognosis.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
277
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
01:29Cardiomyopathy VI: Nursing Management
220
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
220
01:29Cardiomyopathy V: Interprofessional Care
219
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
349
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
349
01:30Cardiomyopathy II: Dilated Cardiomyopathy
330
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
330
01:25Cardiomyopathy I: Introduction and Classification
393
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
393